Financing ·
OPKO Health announced that its $121 million outstanding Convertible Senior Notes due 2029 have become convertible…
OPKOpko Health, Inc.
OPKO Health announced that its $121 million outstanding Convertible Senior Notes due 2029 have become convertible through December 31, 2026. The conversion right was triggered because the common stock closing price exceeded $1.495 (130% of the $1.15 conversion price) for at least 20 of 30 consecutive trading days in the quarter ended September 30, 2026. The company elected to settle conversions in shares rather than cash. Convertible holders will receive approximately 869.57 shares per $1,000 principal amount plus additional shares for early conversion. OPKO Health operates in the biotechnology and diagnostics industry.